My Top Growth Stock to Buy in February

Investors have been taking money out of growth stocks recently in recognition that rising interest rates in the U.S. will likely sap some value from those companies' future profits. Year to date, the tech-heavy Nasdaq Composite index is down about 10% while the broader S&P 500 is off around 5%.

In volatile times like these, it is wise to purchase securities that are likely to continue to perform well long after the dust has settled. Vertex Pharmaceuticals (NASDAQ: VRTX) fits that description -- a solid growth stock that still boasts excellent long-term prospects despite recent struggles.

Continue reading

Source Fool.com